Roundtable Discussion: Debating the Potential of EEGs to be Utilized as Surrogates: What is the Regulatory Perspective on the Use of EEG Biomarker Data?
Time: 3:00 pm
day: EEG Focus Day
Details:
- Are there particular neuropsychiatric indications where it could be valuable to incorporate EEGs as a regulatory endpoint?
- How could we enhance the relevance of EEGs in the eyes of regulators?
- Are there any lessons learned from previous experiences of including EEG data into an IND submission?
